Home > Cashflow Statement > NEULAND LABORATORIES

NEULAND LABORATORIES
Cash Flow from Financing Activities

    Back to Cashflow Statement
NEULAND LABORATORIES is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
Best Quarterly Growth Small Cap Stocks
COMMUNITY POLL
for NEULAND LABORATORIES
Please provide your vote to see the results

NEULAND LABORATORIES Last 5 Year Cash Flow from Financing Activities History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
Cash Flow from Financing Activities ₹-69 Cr₹-136 Cr₹38 Cr₹-114 Cr₹-5.48 Cr

What is the latest Cash Flow from Financing Activities ratio of NEULAND LABORATORIES ?

The latest Cash Flow from Financing Activities ratio of NEULAND LABORATORIES is ₹-69 Cr based on Mar2024 Consolidated results.
Year Cash Flow from Financing Activities
Mar2024₹-69 Cr
Mar2023₹-136 Cr
Mar2022₹38 Cr
Mar2021₹-114 Cr
Mar2020₹-5.48 Cr

How is Cash Flow from Financing Activities of NEULAND LABORATORIES Trending?

Years Cash Flow from Financing Activities % Change
Mar2024 ₹-69 Cr
Negative
Mar2023 ₹-136 Cr
Negative
Mar2022 ₹38 Cr
Positive
Mar2021 ₹-114 Cr
Negative
Mar2020 ₹-5.48 Cr -

Compare Cash Flow from Financing Activities of peers of NEULAND LABORATORIES

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
NEULAND LABORATORIES ₹15,063.6 Cr -19.8% -13.8% 90.3% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹409,003.0 Cr -1.6% -4.6% 14.7% Stock Analytics
DIVIS LABORATORIES ₹154,939.0 Cr -1.6% -1.3% 61.6% Stock Analytics
CIPLA ₹117,835.0 Cr 0.1% 1.2% 3.3% Stock Analytics
DR REDDYS LABORATORIES ₹99,784.6 Cr -2.1% -8.7% -2.3% Stock Analytics
ZYDUS LIFESCIENCES ₹90,722.1 Cr -6.5% -9.3% 8.6% Stock Analytics


NEULAND LABORATORIES Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
NEULAND LABORATORIES

-19.8%

-13.8%

90.3%

SENSEX

-2.5%

-1.4%

6.1%


You may also like the below Video Courses